We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleI-125 versus Pd-103 for low-risk prostate cancer: long-term morbidity outcomes from a prospective randomized multicenter controlled trial.AuthorsHerstein, Andrew; Wallner, Kent; Merrick, Gregory; Mitsuyama, Hiroki; Armstrong, Julius; True, Lawrence; Cavanagh, William; Butler, WayneAbstractWe tested the hypothesis that the shorter half-life of Pd-103 versus I-125 results in different late radiation-related morbidities following prostate brachytherapy.PublicationCancer journal (Sudbury, Mass.), 2005, Vol 11, Issue 5, p385ISSN1528-9117Publication typeJournal ArticleDOI10.1097/00130404-200509000-00005